Literature DB >> 16457974

In vivo human buccal permeability of nicotine.

Charlotte L Adrian1, Helle B D Olin, Kim Dalhoff, Jette Jacobsen.   

Abstract

The aim was to examine the in vivo buccal pH-dependent permeability of nicotine in humans and furthermore compare the in vivo permeability of nicotine to previous in vitro permeability data. The buccal permeability of nicotine was examined in a three-way cross-over study in eight healthy non-smokers using a buccal perfusion cell. The disappearance of nicotine from perfusion solutions with pH 6.0, 7.4, and 8.1 was studied for 3h. The apparent permeability of nicotine (P(app)) was determined at each pH value. Parotid saliva was collected in an attempt to assess systemic levels of nicotine. The disappearance rate of nicotine increased significantly as the pH increased, which resulted in P(app) values of 0.57+/-0.55 x 10(-4), 2.10+/-0.23 x 10(-4), and 3.96+/-0.54 x 10(-4)cms(-1) (mean+/-S.D.) at pH 6.0, 7.4, and 8.1, respectively. A linear relationship (R(2)=0.993) was obtained between the P(app) values and non-ionised nicotine, which indicates that the nicotine transfer occurred by means of passive diffusion. P(app) values of 0.60 x 10(-4) and 6.18 x 10(-4)cms(-1) were obtained for the mono-protonated and non-ionised species of nicotine, respectively. The analysis of the parotid saliva samples indicated that these samples might be useful in the assessment of systemic absorption of nicotine. Previous buccal in vitro models underestimated the in vivo human permeability of nicotine. However, the in vitro models were capable of predicting the effect of pH on the nicotine permeability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457974     DOI: 10.1016/j.ijpharm.2005.12.039

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  In silico prediction of drug permeability across buccal mucosa.

Authors:  Amit Kokate; Xiaoling Li; Paul J Williams; Parminder Singh; Bhaskara R Jasti
Journal:  Pharm Res       Date:  2009-01-30       Impact factor: 4.200

2.  Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets.

Authors:  Thaned Pongjanyakul; Sopaphan Kanjanabat
Journal:  AAPS PharmSciTech       Date:  2012-05-03       Impact factor: 3.246

3.  Preparation and characterization of nicotine-magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery.

Authors:  Sopaphan Kanjanabat; Thaned Pongjanyakul
Journal:  AAPS PharmSciTech       Date:  2011-05-19       Impact factor: 3.246

4.  Gas chromatography-mass spectrometry and high-performance liquid chromotagraphy analysis of the drug absorption characteristics in the buccal mucosa via a circulating device.

Authors:  Xin Wu; Yubo Li; Daoqing Xu; Hong Zhou; Jinlei Wang; Xuejun Guo; Yanjun Zhang
Journal:  Biomed Rep       Date:  2014-11-11

5.  An Analytical Perspective on Determination of Free Base Nicotine in E-Liquids.

Authors:  Vinit V Gholap; Rodrigo S Heyder; Leon Kosmider; Matthew S Halquist
Journal:  J Anal Methods Chem       Date:  2020-03-10       Impact factor: 2.193

Review 6.  Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes?

Authors:  Vinit V Gholap; Leon Kosmider; Laleh Golshahi; Matthew S Halquist
Journal:  Expert Opin Drug Deliv       Date:  2020-09-17       Impact factor: 8.129

7.  A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposure.

Authors:  Ali A Rostami; Jerry L Campbell; Yezdi B Pithawalla; Hamideh Pourhashem; Raheema S Muhammad-Kah; Mohamadi A Sarkar; Jianmin Liu; Willie J McKinney; Robinan Gentry; Maria Gogova
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.